2019
DOI: 10.1016/j.tet.2019.05.064
|View full text |Cite
|
Sign up to set email alerts
|

Process development of ABT-450 – A first generation NS3/4A protease inhibitor for HCV

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
38
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 18 publications
(38 citation statements)
references
References 21 publications
0
38
0
Order By: Relevance
“…Multicomponent crystal forms of pharmaceuticals, especially hydrates, are frequently observed (Stahly, 2007;Cruz-Cabeza et al, 2015) and are increasingly common in recently approved drugs (Caspi et al, 2019;Cink et al, 2020;Califano et al, 2016;Brackemeyer et al, 2017;Pangan et al, 2018). Hydrates, solvates and cocrystals present challenges during development because of the implications for in vivo solubility, manufacturing and storage (Hilfiker et al, 2006;Pudipeddi & Serajuddin, 2005;Threlfall, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Multicomponent crystal forms of pharmaceuticals, especially hydrates, are frequently observed (Stahly, 2007;Cruz-Cabeza et al, 2015) and are increasingly common in recently approved drugs (Caspi et al, 2019;Cink et al, 2020;Califano et al, 2016;Brackemeyer et al, 2017;Pangan et al, 2018). Hydrates, solvates and cocrystals present challenges during development because of the implications for in vivo solubility, manufacturing and storage (Hilfiker et al, 2006;Pudipeddi & Serajuddin, 2005;Threlfall, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Grazoprevir and asunaprevir both contain vinyl-ACCA, whereas simeprevir 261 and paritaprevir 262 require its incorporation to allow for macrocyclisation through ring-closing metathesis. 263 The synthesis of vinyl-ACCA as outlined by Boehringer Ingelheim in 2005 is regarded as the gold standard for the production of this compound (Scheme 42A). 264 Their synthetic strategy involved resolution of the N-Boc-protected vinyl-ACCA methyl ester (cis-190) by Alcalase 2.4L (a Bacillus licheniformis protease formulation).…”
Section: Review Articlementioning
confidence: 99%
“…After peptide coupling of vinyl-ACCA (199), L-hydroxyproline ((2S,4R)-186) and L-6-heptenylglycine (198), ring-closing metathesis of the two terminal olefins allowed for the synthesis of paritaprevir (Scheme 44A). 263 Resolution of the N-acetylprotected racemate with acylase I afforded L-6-heptenylglycine with 499% ee on large scale. 272 Alternatively, the corresponding N-Boc-protected precursor could be resolved by subjecting its ethyl ester to protease-catalysed hydrolysis.…”
Section: Review Articlementioning
confidence: 99%
“…RCM macrocyclization (mRCM) represents a methodology of major current interest for the production of antiviral therapeutics. 7 , 20 The first indication that even low concentrations of water might impede mRCM emerged in reactions involving the dianiline catalyst Ru-1 ( Chart 1 ). In our hands, Ru-1 was exceptionally efficient, 21 outperforming even the leading nitro-Grela catalyst Ru-2 in mRCM of challenging, highly flexible substrates bearing multiple polar sites.…”
mentioning
confidence: 99%